NEKTAR THERAPEUTICS — Form D
NEKTAR THERAPEUTICS of San Francisco, CA, a company, filed a Form D exempt-offering notice with the SEC on 2024-03-19. The offering totals $30.0M, of which $30.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2024-03-19
- Form: D
- Accession: 0000950123-24-002925
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $30.0M
- Amount sold: $30.0M
- Investors: 1
- Date of first sale: 2024-03-04
- Security types: equity
- Revenue range: $25,000,001 - $100,000,000
- SEC file number: 021-508055
Issuer
- Name: NEKTAR THERAPEUTICS
- CIK: 0000906709
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 455 Mission Bay Boulevard South, San Francisco, CA, 94158
- Phone: 415-482-5300
Officers, directors & promoters (20)
| Name | Role | Location |
|---|
| Jeffrey R Ajer | Director | San Francisco, CA |
| Diana M Brainard | Director | San Francisco, CA |
| Robert B Chess | Director | San Francisco, CA |
| R. Scott M Greer | Director | San Francisco, CA |
| Howard W Robin | Director | San Francisco, CA |
| Roy A Whitfield | Director | San Francisco, CA |
| Sandra W Gardiner | Executive Officer | San Francisco, CA |
| Howard W Robin | Executive Officer | San Francisco, CA |
| Mark A Wilson | Executive Officer | San Francisco, CA |
| Jonathan A Zalevsky | Executive Officer | San Francisco, CA |
| Lutz A Lingnau | Director | San Francisco, CA |
| Gil M Labrucherie | Executive Officer | San Francisco, CA |
| Maninder K Hora | Executive Officer | San Francisco, CA |
| Stephen K Doberstein | Executive Officer | San Francisco, CA |
| John K Nicholson | Executive Officer | San Francisco, CA |
| Jillian B Thomsen | Executive Officer | San Francisco, CA |
| Christopher A Kuebler | Director | San Francisco, CA |
| Jeff R Ajer | Director | San Francisco, CA |
| R. Scott R Greer | Director | San Francisco, CA |
| DENNIS L WINGER | Director | SOUTH SAN FRANCISCO, CA |
Other filings by this issuer (1)
More